Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.